Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Cited by
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
“…antimicrobial peptide RegIIIg not only contributes to maintenance of segregation between the microbiota and host epithelial cells, but also promotes protection against defined pathogens, such as vancomycin-resistant Enterococcus faecalis (Brandl et al., 2008; Vaishnava et al., 2008, 2011).”
BackgroundInduction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
“Our results are also consistent with the report that a vancomycin-sensitive component of the commensal microbiota induces RegIIIg in the mouse small intestine, thus reducing colonization by VRE and enhancing killing of the pathogen (Brandl et al., 2008).”
ResultGut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
“prolong their colonization of the infected murine host (28).”
BackgroundThe rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
“Pioneering work using mouse models of intestinal colonizatio”
MethodControl of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Self-citationRoy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Vaishnava, S., Yamamoto, M., Severson, K. M., Ruhn, K. A., Yu, X., Koren, O., Ley, R., Wakeland, E. K., & Hooper, L. V. (2011) · Science · doi:10.1126/science.1209791 · Cited by 1,412
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288
“Treatment of mice with broad-spectrum antibiotics decreased the expression of REG3γ, an effect that was ameliorated by oral administration of LP”
BackgroundPaneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
Bevins, C. L., & Salzman, N. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2546 · Cited by 1,238
“In part, it may be due to beneficial immune responses that are induced by specific members of the microbiota (microbiota–host interactions”
BackgroundTh17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
Epithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3228 · Cited by 957
Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances
Francino, M. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01543 · Cited by 945
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., Viale, A., Socci, N. D., van den Brink, M. R. M., Kamboj, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43918 · Cited by 943
“Reg3γ expression and susceptibility to VRE colonization in antibiotic-treated mice is restored by administration of oral LPS or systemic flagellin, which enhances VRE killing (17, 27).”
BackgroundResultInfluentialSelf-citationAntibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of antimicrobial peptides [AMPs]) [18,19].”
BackgroundInfluentialSelf-citationImpact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
“Germ‐free mice colonized with conventional or human mi- crobiota or specific probiotic species or LPS demonstrated increased production of antimicrobial peptides like REGIII‐γ, boosting the in- nate immune response (Brandl et al., 2008; Cash et al., 2006; Natividad et al., 2013).”
BackgroundEnteric dysbiosis associated with a mouse model of alcoholic liver disease
Yan, A. W., Fouts, D. E., Brandl, J., Stärkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2011) · Hepatology · doi:10.1002/hep.24018 · Cited by 791
“As we have reported, Reg3g is a secreted c-type lectin with potent bactericidal activity that is expressed in intestinal epithelial and Paneth cells, with highest levels found in the ileum.(32,33) Similarly, Reg3b has antimicrobial activity and has been implicated in intestinal homeostasis.”
BackgroundSelf-citationThe microbiome in infectious disease and inflammation
Honda, K., & Littman, D. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074937 · Cited by 791
“Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection.”
Shifting the balance: antibiotic effects on host–microbiota mutualism
Willing, B. P., Russell, S. L., & Finlay, B. B. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2536 · Cited by 747
“Therefore, disturbances in a healthy adult microbiota can create opportunities for pathogens to infect and increase disease severit”
BackgroundThe intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Self-citationThe immune system and the gut microbiota: friends or foes?
Cerf-Bensussan, N., & Gaboriau-Routhiau, V. (2010) · Nature Reviews Immunology · doi:10.1038/nri2850 · Cited by 704
“This hypothesis is also supported by recent work that shows that the destruction of the microbiota following treatment with antibiotics can jeopardize innate immune responses in the gut and promote colonization by pathogen”
ResultAntibiotics and the Gut Microbiota
Modi, S. R., Collins, J. J., & Relman, D. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72333 · Cited by 667
“As antibiotics are currently our main line of defense against bacterial infections, it will be important to take advantage of insights from the emergence of resistance in vivo to innovate strat-to actively protect against infections of the intestine (61, 62).”
Gut Microbiota Promote Hematopoiesis to Control Bacterial Infection
Khosravi, A., Yáñez, A., Price, J. G., Chow, A., Merad, M., Goodridge, H. S., & Mazmanian, S. K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.006 · Cited by 644
Intestinal colonization resistance
Lawley, T. D., & Walker, A. W. (2013) · Immunology · doi:10.1111/j.1365-2567.2012.03616.x · Cited by 610
Effects of antibiotics on gut microbiota
Lange, K., Buerger, M., Stallmach, A., & Bruns, T. (2016) · Digestive Diseases · doi:10.1159/000443360 · Cited by 607
Kennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602
The gut microbiota, obesity and insulin resistance
Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599
“In addition, MyD88-dependent upregulation of endogenous host antibacterial compounds is essential for controlling intestinal barrier penetration by commensal and pathogenic bacteria (Brandl et al., 2007, 2008; Vaishnava et al., 2008).”
BackgroundBuffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.05496-11 · Cited by 596
“difficile colonization resistance may be direct or indirect, since work from our group has shown that microbial products augment innate immune barrier function (3, 23) and confer resistance to C.”
BackgroundSelf-citationSawa, S., Lochner, M., Satoh-Takayama, N., Dulauroy, S., Bérard, M., Kleinschek, M., Cua, D., Di Santo, J. P., & Eberl, G. (2011) · Nature Immunology · doi:10.1038/ni.2002 · Cited by 568
“Perturbation of homeostasis leads either to inflammatory disease characterized by immune attack on microbial symbionts and tissue destruction, the scenario that unfolds during inflammatory bowel disease, or (in contrast) to low reactivity of the intestinal immune system and greater susceptibility to pathogen”
BackgroundNod2 is required for the regulation of commensal microbiota in the intestine
Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.-J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., & Kobayashi, K. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907722106 · Cited by 564
“MyD88 also is known to control intestinal infection by pathogenic bacteria such as Listeria monocytogenes or vancomycin-resistant Enterococcus through an increased expression of antimicrobials (32, 33).”
BackgroundRole of the Commensal Microbiota in Normal and Pathogenic Host Immune Responses
Littman, D. R., & Pamer, E. G. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.004 · Cited by 556
“In this setting, LPS-induced RegIIIγ expression results from MyD88mediated signaling in non-hematopoietic, presumably epithelial cells, and thus simulates commensal-driven RegIIIγ induction (Brandl et al., 2008).”
BackgroundSelf-citationReproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., & Young, V. B. (2009) · Infection and Immunity · doi:10.1128/iai.01520-08 · Cited by 550
“cases they appear to be protective (5, 9, 24, 26, 52).”
BackgroundAntibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome
Modi, S. R., Lee, H. H., Spina, C. S., & Collins, J. J. (2013) · Nature · doi:10.1038/nature12212 · Cited by 542
“Antibiotic treatment, an important and often necessary therapeutic intervention, can negatively impact the mammalian gut environment, potentially giving rise to immune 2 and metabolic deficiencies 8 .”
Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression
Reikvam, D. H., Erofeev, A., Sandvik, A., Grcic, V., Jahnsen, F. L., Gaustad, P., McCoy, K. D., Macpherson, A. J., Meza-Zepeda, L. A., & Johansen, F.-E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017996 · Cited by 542
Antibiotics, Pediatric Dysbiosis, and Disease
Vangay, P., Ward, T., Gerber, J. S., & Knights, D. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.006 · Cited by 530
Fiore, E., Van Tyne, D., & Gilmore, M. S. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0053-2018 · Cited by 503
“faecium in the antibiotic perturbed gut include reduced expression of the host innate immune factor RegIIIγ, which results indirectly from the loss of gram-negative members of the gut microflora (90).”
BackgroundKinnebrew, M. A., Buffie, C. G., Diehl, G. E., Zenewicz, L. A., Leiner, I., Hohl, T. M., Flavell, R. A., Littman, D. R., & Pamer, E. G. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.011 · Cited by 491
“Lipopolysaccharide (LPS) and flagellin stimulate TLR4 and TLR5, respectively, aswell as induce RegIIIg expression and restrict colonization of the gut by VRE (Brandl et al., 2008; Kinnebrew et al., 2010).”
InfluentialSelf-citationMicrobiota-mediated colonization resistance: mechanisms and regulation
Caballero-Flores, G., Pickard, J. M., & Núñez, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00833-7 · Cited by 474
Ubeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N. C., Equinda, M., Lipuma, L., Ling, L., Gobourne, A., No, D., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01197-12 · Cited by 466
“Previous studies demonstrated that intestinal colonization by VRE can be suppressed by MyD88-dependent and microbiotamediated induction of RegIII expression by epithelial cells (15).”
BackgroundSelf-citationAdvances in sustainable approaches to recover metals from e-waste-A review
Islam, A., Ahmed, T., Awual, M. R., Rahman, A., Sultana, M., Aziz, A. A., Monir, M. U., Teo, S. H., & Hasan, M. (2020) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2019.118815 · Cited by 451
Kommineni, S., Bretl, D. J., Lam, V., Chakraborty, R., Hayward, M., Simpson, P., Cao, Y., Bousounis, P., Kristich, C. J., & Salzman, N. H. (2015) · Nature · doi:10.1038/nature15524 · Cited by 458
“Prior antibiotic therapy is a well-known risk factor for enterococcal infection 9, 11 .”
From Structure to Function: the Ecology of Host-Associated Microbial Communities
Robinson, C. J., Bohannan, B. J. M., & Young, V. B. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-10 · Cited by 457
Pathobionts of the gastrointestinal microbiota and inflammatory disease
Chow, J., Tang, H., & Mazmanian, S. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.010 · Cited by 448
Ahmed, M. O., & Baptiste, K. E. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0147 · Cited by 438
Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens
Pamer, E. G. (2016) · Science · doi:10.1126/science.aad9382 · Cited by 418
Self-citationMechanisms controlling pathogen colonization of the gut
Stecher, B., & Hardt, W.-D. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.10.003 · Cited by 421
Franchi, L., Kamada, N., Nakamura, Y., Burberry, A., Kuffa, P., Suzuki, S., Shaw, M. H., Kim, Y.-G., & Núñez, G. (2012) · Nature Immunology · doi:10.1038/ni.2263 · Cited by 390
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?
Guzman Prieto, A. M., van Schaik, W., Rogers, M. R. C., Coque, T. M., Baquero, F., Corander, J., & Willems, R. J. L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00788 · Cited by 385
“Worryingly, resistance to antibiotics that are used to treat vancomycin resistant enterococci (VRE), like linezolid, tigecycline, and daptomycin, has already been reported (Aksoy and Unal, 2008; Montero et al., 2008; Scheetz et al., 2008; Niebel et al., 2015).”
InfluentialLactose drives Enterococcus expansion to promote graft-versus-host disease
Stein-Thoeringer, C. K., Nichols, K. B., Lazrak, A., Docampo, M. D., Slingerland, A. E., Slingerland, J. B., Clurman, A. G., Armijo, G., Gomes, A. L. C., Shono, Y., et al. (2019) · Science · doi:10.1126/science.aax3760 · Cited by 384
Self-citationWang, L., Fouts, D. E., Stärkel, P., Hartmann, P., Chen, P., Llorente, C., DePew, J., Moncera, K., Ho, S. B., Brenner, D. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.003 · Cited by 389
Self-citationWlodarska, M., Willing, B., Keeney, K. M., Menendez, A., Bergstrom, K. S., Gill, N., Russell, S. L., Vallance, B. A., & Finlay, B. B. (2011) · Infection and Immunity · doi:10.1128/iai.01104-10 · Cited by 382
Mucosal immunity to pathogenic intestinal bacteria
Perez-Lopez, A., Behnsen, J., Nuccio, S.-P., & Raffatellu, M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.17 · Cited by 375
Hendrikx, T., Duan, Y., Wang, Y., Oh, J.-H., Alexander, L. M., Huang, W., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 361
Self-citationZgadzaj, R., Garrido-Oter, R., Jensen, D. B., Koprivova, A., Schulze-Lefert, P., & Radutoiu, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616564113 · Cited by 358
Antibiotics, microbiota, and immune defense
Ubeda, C., & Pamer, E. G. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.003 · Cited by 356
Self-citationLawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00558-09 · Cited by 349
“Although we did not monitor the transmission of Enterococcus and E. coli in our experiments, it has previously been documented that transmission of Enterococcus (18) and S. enterica (34) increases significantly after treatment of infected hosts with antibiotics.”
BackgroundInfluentialToll-like receptors in inflammatory bowel diseases: A decade later
Cario, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21282 · Cited by 336
“Decreased expression of Paneth cell a-defensins has recently been associated with increased susceptibility to develop CD ileitis.69 MyD88-dependent signaling, presumably via TLR2/4,19,70,71 is crucial for lim- iting mucosal adherence and penetration of commensals through production of Paneth cell a-defensins16 and Reg…”
BackgroundSassone-Corsi, M., & Raffatellu, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403169 · Cited by 328
Antimicrobial Defense of the Intestine
Mukherjee, S., & Hooper, L. V. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.028 · Cited by 318
Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota
Peterson, C. T., Sharma, V, Elmén, L., & Peterson, S. N. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12474 · Cited by 318
Modulation of immune development and function by intestinal microbiota
Kabat, A. M., Srinivasan, N., & Maloy, K. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.07.010 · Cited by 314
Gut microbiota injury in allogeneic haematopoietic stem cell transplantation
Shono, Y., & van den Brink, M. R. M. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.10 · Cited by 309
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311
Self-citationUbeda, C., Lipuma, L., Gobourne, A., Viale, A., Leiner, I., Equinda, M., Khanin, R., & Pamer, E. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120504 · Cited by 310
“VRE colonization of the small intestine is facilitated by antibiotic-mediated depletion of the commensal flora, and stimulation of TLR4 by oral LPS or TLR5 by systemic flagellin enhances resistance to VRE colonization (Brandl et al., 2008; Kinnebrew et al., 2010).”
BackgroundSelf-citationCooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium
Caballero, S., Kim, S., Carter, R. A., Leiner, I. M., Sušac, B., Miller, L., Kim, G. J., Ling, L., & Pamer, E. G. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.002 · Cited by 308
“, 2011), and downregulation of the bactericidal C-type lectin RegIIIg (Brandl et al., 2008; Kinnebrew et al., 2010) were reversed by ARM administration to ampicillin-treated C57BL/6 mice, indicating that ARM corrects defective fiber degradation and provides the stimuli to trigger mucin production and innate immune res…”
InfluentialSelf-citationHow uterine microbiota might be responsible for a receptive, fertile endometrium
Benner, M., Ferwerda, G., Joosten, I., & van der Molen, R. G. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy012 · Cited by 304
Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks
Morgun, A., Dzutsev, A., Dong, X., Greer, R. L., Sexton, D. J., Ravel, J., Schuster, M., Hsiao, W., Matzinger, P., & Shulzhenko, N. (2015) · Gut · doi:10.1136/gutjnl-2014-308820 · Cited by 306
Qi, X., Zhang, Y., Zhang, Y., Luo, F., Song, K., Wang, G., & Ling, F. (2023) · Microbiome · doi:10.1186/s40168-023-01574-2 · Cited by 285
Bridging intestinal immunity and gut microbiota by metabolites
Wang, G., Huang, S., Wang, Y., Cai, S., Yu, H., Liu, H., Zeng, X., Zhang, G., & Qiao, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03190-6 · Cited by 293
“In addition, mice treated with a mixture of antibiotics consisting of vancomycin, neomycin, and metronidazole exhibit reduced antimicrobial peptide expression [37].”
BackgroundResident viruses and their interactions with the immune system
Duerkop, B. A., & Hooper, L. V. (2013) · Nature Immunology · doi:10.1038/ni.2614 · Cited by 294
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
“However, a recent study suggested that a specific intestinal bacterial consortium facilitates the clearance of the VRE species, which works independently of the host innate immune pathways, such as MYD88 signaling (Ubeda et al., 2013).”
BackgroundInfluentialTargeting the gut microbiota for cancer therapy
Fernandes, M. R., Aggarwal, P., Costa, R. G. F., Cole, A. M., & Trinchieri, G. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00513-x · Cited by 290
Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus
Kim, S. G., Becattini, S., Moody, T. U., Shliaha, P. V., Littmann, E. R., Seok, R., Gjonbalaj, M., Eaton, V., Fontana, E., Amoretti, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1501-z · Cited by 283
Self-citationMa, N., & Ma, X. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12401 · Cited by 274
Enterococcal Infection—Treatment and Antibiotic Resistance
Kristich, C. J., Rice, L. B., & Arias, C. A. (2014) · Europe PMC (PubMed Central) · Cited by 315
Mason, K. L., Erb Downward, J. R., Mason, K. D., Falkowski, N. R., Eaton, K. A., Kao, J. Y., Young, V. B., & Huffnagle, G. B. (2012) · Infection and Immunity · doi:10.1128/iai.00449-12 · Cited by 275
Reeves, A. E., Theriot, C. M., Bergin, I. L., Huffnagle, G. B., Schloss, P. D., & Young, V. B. (2011) · Gut Microbes · doi:10.4161/gmic.2.3.16333 · Cited by 270
“com Gut Microbes 153 Enterococcus.(41) However, in our animals we did not find a direct relationship between changes in RegIIIγ expression following antibiotic treatment and colonization resistance to C.”
BackgroundLai, Y., Li, D., Li, C., Muehleisen, B., Radek, K. A., Park, H. J., Jiang, Z., Li, Z., Lei, H., Quan, Y., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.010 · Cited by 261
“named heptocarcinoma-intestine-pancreas (HIP) or pancreatic associated protein (PAP), functions as an antimicrobial protein in control of the bacterial proliferation (Brandl et al., 2008; Cash et al., 2006; Vaishnava et al., 2011).”
BackgroundCoordination of tolerogenic immune responses by the commensal microbiota
Round, J. L., O'Connell, R. M., & Mazmanian, S. K. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.007 · Cited by 264
Antibiotics in early life: dysbiosis and the damage done
Neuman, H., Forsythe, P., Uzan, A., Avni, O., & Koren, O. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy018 · Cited by 259
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00796-x · Cited by 257
Self-citationDo symbiotic bacteria subvert host immunity?
Hooper, L. V. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2114 · Cited by 255
“Second, TLR-dependent expression of epithelial antimicrobial proteins can be activated in healthy, immunocompetent mice through oral feeding of LP”
BackgroundTh17 Cytokines and the Gut Mucosal Barrier
Blaschitz, C., & Raffatellu, M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9368-7 · Cited by 248
“rodentium or vancomycin-resistant enterococci [34, 66].”
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice
Hartmann, P., Chen, P., Wang, H. J., Wang, L., McCole, D. F., Brandl, K., Stärkel, P., Belzer, C., Hellerbrand, C., Tsukamoto, H., et al. (2013) · Hepatology · doi:10.1002/hep.26321 · Cited by 246
“To investigate whether these findings directly translate into quantitative alterations of the commensal microflora, we used an in vivo luminal killing assay of nonpathogenic Escherichia coli in the gut of wild-type and Muc2-deficient mice as described by us.(35,36) A 4cm loop of the proximal jejunum was ligated (witho…”
MethodSelf-citationWeber, D., Jenq, R. R., Peled, J. U., Taur, Y., Hiergeist, A., Koestler, J., Dettmer, K., Weber, M., Wolff, D., Hahn, J., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2017.02.006 · Cited by 245
Self-citationFreedberg, D. E., Zhou, M. J., Cohen, M. E., Annavajhala, M. K., Khan, S., Moscoso, D. I., Brooks, C., Whittier, S., Chong, D. H., Uhlemann, A.-C., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5268-8 · Cited by 242
“Selective killing of Gram-negative bacteria by antibiotics reduces RegIII-γ levels and allows expansion of Gram-positives including Enterococcus [32].”
Microbiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
“F or p er so na l u se o nl y. stimulation can enhance resistance to VRE colonization, in part by stimulating the production of RegIIIγ expression in the small intestine (96, 103).”
InfluentialSelf-citationZeissig, S., & Blumberg, R. S. (2014) · Nature Immunology · doi:10.1038/ni.2847 · Cited by 236
Kinnebrew, M. A., Ubeda, C., Zenewicz, L. A., Smith, N., Flavell, R. A., & Pamer, E. G. (2010) · The Journal of Infectious Diseases · doi:10.1086/650203 · Cited by 236
“In the small intestine, the pattern of RegIIIg expression, along with other AMPs, reflects the density of microbial colonization, which increases in the cephalocaudal direction [13].”
BackgroundInfluentialSelf-citationBritton, R. A., & Young, V. B. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.04.001 · Cited by 240
“difficile colonization, similar to previous work with vancomycin resistant Enterococcus infection [48].”
ResultDisruption of the gut microbiome as a risk factor for microbial infections
Khosravi, A., & Mazmanian, S. K. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.009 · Cited by 241
“VRE is a common cause of antibiotic-associated diarrhea and, similar to C. difficile, exceedingly difficult to treat.”
BackgroundInfluentialEnterococci and Their Interactions with the Intestinal Microbiome
Dubin, K., & Pamer, E. G. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0014-2016 · Cited by 239
Self-citationGut Commensal Bacteria Direct a Protective Immune Response against Toxoplasma gondii
Benson, A., Pifer, R., Behrendt, C. L., Hooper, L. V., & Yarovinsky, F. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.06.005 · Cited by 229
“Beneficial relationships between commensal microorganisms and the host immune system are increasingly evident (Hooper et al., 2001; Rakoff-Nahoum et al., 2004; Bäckhed et al., 2005; Artis, 2008; Brandl et al., 2008; Mazmanian et al., 2008).”
BackgroundInnate immune response to Salmonella typhimurium , a model enteric pathogen
Broz, P., Ohlson, M. B., & Monack, D. M. (2012) · Gut Microbes · doi:10.4161/gmic.19141 · Cited by 226
“RegIIIc secretion contributes to the clearance of other intestinal pathogens such as Listeria monocytogenes and Enterococcus spp.(18) However, unlike these pathogens Salmonella is better adapted to counter host defenses and might even profit from increased production of C-type lectins to gain a growth advantage over t…”
BackgroundA new vision of immunity: homeostasis of the superorganism
Eberl, G. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.20 · Cited by 224
Commensal microbes provide first line defense against Listeria monocytogenes infection
Becattini, S., Littmann, E. R., Carter, R. A., Kim, S. G., Morjaria, S. M., Ling, L., Gyaltshen, Y., Fontana, E., Taur, Y., Leiner, I. M., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170495 · Cited by 219
Self-citationAntibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1843396 · Cited by 207
“Bl. producta inhibits VRE growth by producing a lantibiotic similar to nisin A (Kim et al. 2019).”
BackgroundInfluentialEpithelial barrier: an interface for the cross‐communication between gut flora and immune system
Goto, Y., & Kiyono, H. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01078.x · Cited by 212
“Of these antimicrobial molecules, RegIIIc, which is mediated by TLR4–MyD88 signaling cascades controlled by commensal bacteria-derived LPS, is critical in the prevention of infection by vancomycin-resistant Enterococcus (51).”
Background
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.